Barrett's esophagus screening: Difference between revisions
Jump to navigation
Jump to search
Amresh Kumar (talk | contribs) No edit summary |
Amresh Kumar (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Barrett's esophagus is a major [[risk factor]] for [[development]] of [[esophageal]] [[adenocarcinoma]]. After [[diagnosis]], regular surveillance is needed based on the grade of [[dysplasia]]. | [[Barrett's esophagus]] is a major [[risk factor]] for [[development]] of [[esophageal]] [[adenocarcinoma]]. After [[diagnosis]], regular surveillance is needed based on the grade of [[dysplasia]]. | ||
* Weak recommendation, moderate-quality [[evidence]]: [[screening]] in [[patients]] with multiple [[risk factors]] for [[esophageal]] [[adenocarcinoma]]: | * Weak recommendation, moderate-quality [[evidence]]: [[screening]] in [[patients]] with multiple [[risk factors]] for [[esophageal]] [[adenocarcinoma]]: | ||
| Line 15: | Line 15: | ||
* [[Strong]] [[recommendation]], low-quality [[evidence]]: | * [[Strong]] [[recommendation]], low-quality [[evidence]]: | ||
# [[Recommend]] [[against]] [[screening]] [[general]] [[population]] [[with]] [[GERD]] and no [[risk factors]].<ref name="pmid21376940">{{cite journal |author=Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ |title=American Gastroenterological Association medical position statement on the management of Barrett's esophagus |journal=Gastroenterology |volume=140 |issue=3 |pages=1084–91 |year=2011 |month=March |}}</ref> | # [[Recommend]] [[against]] [[screening]] [[general]] [[population]] [[with]] [[GERD]] and no [[risk factors]].<ref name="pmid21376940">{{cite journal |author=Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ |title=American Gastroenterological Association medical position statement on the management of Barrett's esophagus |journal=Gastroenterology |volume=140 |issue=3 |pages=1084–91 |year=2011 |month=March |}}</ref> | ||
==Screening== | ==Screening== | ||
Revision as of 00:27, 3 February 2018
|
Barrett's Esophagus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Barrett's esophagus screening On the Web |
|
American Roentgen Ray Society Images of Barrett's esophagus screening |
|
Risk calculators and risk factors for Barrett's esophagus screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amresh Kumar MD [2]
Overview
Barrett's esophagus is a major risk factor for development of esophageal adenocarcinoma. After diagnosis, regular surveillance is needed based on the grade of dysplasia.
- Weak recommendation, moderate-quality evidence: screening in patients with multiple risk factors for esophageal adenocarcinoma:
- Age : > 50 years old
- Sex : male
- Race: white
- Other: chronic GERD, hiatal hernia, elevated BMI (body mass index), and intra-abdominal distribution of body fat.
- Strong recommendation, low-quality evidence:
Screening
Weak recommendation, moderate-quality evidence: Endoscopic surveillance in patients with Barrett's esophagus The following intervals are recommended:
- High-grade dysplasia in the absence of eradication therapy: 3 months.[1]